APS guidlines.pdf
1.7 MB
B S H G u i d e l i n e
Guidelines on the investigation and management of
antiphospholipid syndrome
Guidelines on the investigation and management of
antiphospholipid syndrome
https://file.kfshrc.edu.sa/portal/r/l/a568e59ae376418ab5ec0f5eacf23935
2025 KFSHRC Hematology Board Review
Password 123456789
Old link not working anymore
This is New link
2025 KFSHRC Hematology Board Review
Password 123456789
Old link not working anymore
This is New link
Academic sources
KFSH 2026
https://drive.google.com/drive/folders/1drQ8E-PNCVb3Ef0S1pE0yxcnFDD3xTgx?usp=sharing
Dr. Alfadel Alshaibani 2026
https://drive.google.com/drive/folders/1ZkWH7G4qX63sQI5ZNTlrm8OqnfWXXmn6?dmr=1&ec=wgc-drive-%5Bmodule%5D-goto
KFSH 2025
https://1drv.ms/f/c/d0d0de2fa94d8f8d/Eo2PTakv3tAggNCiYAAAAAAB-Nc8qrpWwSLOrYDe2mpaPA
Reviews
https://u.pcloud.link/publink/show?code=kZ3y4RVZTz5ORkUkX2hVNC1owywVpXdOIO9V#
KFSH 2026
https://drive.google.com/drive/folders/1drQ8E-PNCVb3Ef0S1pE0yxcnFDD3xTgx?usp=sharing
Dr. Alfadel Alshaibani 2026
https://drive.google.com/drive/folders/1ZkWH7G4qX63sQI5ZNTlrm8OqnfWXXmn6?dmr=1&ec=wgc-drive-%5Bmodule%5D-goto
KFSH 2025
https://1drv.ms/f/c/d0d0de2fa94d8f8d/Eo2PTakv3tAggNCiYAAAAAAB-Nc8qrpWwSLOrYDe2mpaPA
Reviews
https://u.pcloud.link/publink/show?code=kZ3y4RVZTz5ORkUkX2hVNC1owywVpXdOIO9V#
Pocket Medicine 9th decrypted version😎.pdf
17.5 MB
Pocket Medicine 🗞️💜
9th edition
9th edition
American_J_Hematol_2026_Rajkumar_Multiple_Myeloma_2026_Update_on.pdf
566.5 KB
Multiple Myeloma: 2026 Update on Diagnosis,
Risk- Stratification and Management
Risk- Stratification and Management
pdf.pdf
1.3 MB
Factor XIII deficiency: an updated
approach to diagnosis and
management
approach to diagnosis and
management
🩸 Emergency surgery in APS patient on warfarin
SLE + thrombotic antiphospholipid syndrome (APS) + pulmonary embolism 4 months ago = high perioperative thrombosis risk, but emergency laparotomy requires reliable hemostasis.
🚨 Before OR
🔹 Stop warfarin immediately.
🔹 Confirm current INR, CBC, fibrinogen, renal/liver function and last warfarin dose.
🔹 For immediate surgery with INR 2:
💉 4-factor PCC 25 IU/kg IV
• Maximum 2,500 IU for INR 2–<4
• Dose according to local protocol/product
➕ Vitamin K 5–10 mg IV slowly for sustained reversal
🎯 Recheck INR approximately 30 minutes after PCC; commonly aim INR ≤1.5 before major abdominal surgery, according to surgical/anesthetic requirements.
⚠️ PCC acts rapidly but carries thrombotic risk—use only the required dose.
❌ Do not delay life-saving surgery waiting for vitamin K alone.
❌ Fresh frozen plasma is unnecessary when 4-factor PCC is available; consider it only if PCC is unavailable.
🛡️ Prevent postoperative thrombosis
🔹 Intermittent pneumatic compression immediately.
🔹 Start prophylactic UFH/LMWH once surgical hemostasis is secure—often within 12–24 hours.
🔹 Because thrombotic APS is high risk, escalate to therapeutic UFH/LMWH when bleeding risk permits—commonly 48–72 hours after major abdominal surgery, individualized with surgery/hematology.
🔹 UFH may be preferred if renal impairment, uncertain hemostasis or possible reoperation because it is short-acting and reversible.
🔹 Restart warfarin when enteral intake and hemostasis allow, overlapping with heparin until the INR is therapeutic.
🧠 APS pearl: Lupus anticoagulant may prolong aPTT; if UFH monitoring appears unreliable, use a validated anti-Xa assay.
✅ The principle: rapid, controlled warfarin reversal for surgery—then minimize time without anticoagulation.
❓ MCQ: Best immediate reversal for INR 2 before emergency laparotomy?
A. Vitamin K alone
B. FFP alone
C. 4-factor PCC + IV vitamin K ✅
D. Platelet transfusion
🎭 OSCE: State the competing risks, stop warfarin, administer PCC plus vitamin K, verify INR, ensure mechanical prophylaxis, and establish a documented postoperative heparin/warfarin restart plan.
References: 4-factor PCC prescribing information—DailyMed, 2025 warfarin-reversal recommendations, EULAR APS recommendations
#APS #Warfarin #Anticoagulation #EmergencySurgery #Hematology
SLE + thrombotic antiphospholipid syndrome (APS) + pulmonary embolism 4 months ago = high perioperative thrombosis risk, but emergency laparotomy requires reliable hemostasis.
🚨 Before OR
🔹 Stop warfarin immediately.
🔹 Confirm current INR, CBC, fibrinogen, renal/liver function and last warfarin dose.
🔹 For immediate surgery with INR 2:
💉 4-factor PCC 25 IU/kg IV
• Maximum 2,500 IU for INR 2–<4
• Dose according to local protocol/product
➕ Vitamin K 5–10 mg IV slowly for sustained reversal
🎯 Recheck INR approximately 30 minutes after PCC; commonly aim INR ≤1.5 before major abdominal surgery, according to surgical/anesthetic requirements.
⚠️ PCC acts rapidly but carries thrombotic risk—use only the required dose.
❌ Do not delay life-saving surgery waiting for vitamin K alone.
❌ Fresh frozen plasma is unnecessary when 4-factor PCC is available; consider it only if PCC is unavailable.
🛡️ Prevent postoperative thrombosis
🔹 Intermittent pneumatic compression immediately.
🔹 Start prophylactic UFH/LMWH once surgical hemostasis is secure—often within 12–24 hours.
🔹 Because thrombotic APS is high risk, escalate to therapeutic UFH/LMWH when bleeding risk permits—commonly 48–72 hours after major abdominal surgery, individualized with surgery/hematology.
🔹 UFH may be preferred if renal impairment, uncertain hemostasis or possible reoperation because it is short-acting and reversible.
🔹 Restart warfarin when enteral intake and hemostasis allow, overlapping with heparin until the INR is therapeutic.
🧠 APS pearl: Lupus anticoagulant may prolong aPTT; if UFH monitoring appears unreliable, use a validated anti-Xa assay.
✅ The principle: rapid, controlled warfarin reversal for surgery—then minimize time without anticoagulation.
❓ MCQ: Best immediate reversal for INR 2 before emergency laparotomy?
A. Vitamin K alone
B. FFP alone
C. 4-factor PCC + IV vitamin K ✅
D. Platelet transfusion
🎭 OSCE: State the competing risks, stop warfarin, administer PCC plus vitamin K, verify INR, ensure mechanical prophylaxis, and establish a documented postoperative heparin/warfarin restart plan.
References: 4-factor PCC prescribing information—DailyMed, 2025 warfarin-reversal recommendations, EULAR APS recommendations
#APS #Warfarin #Anticoagulation #EmergencySurgery #Hematology